T. Dang

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · Annals of Oncology · 2019 · 38 citations · Full text

P1.01-81 Phase 3 Study of Pemetrexed-Platinum with or without Pembrolizumab for TKI-Resistant/EGFR-Mutated Advanced NSCLC: KEYNOTE-789

Greg J. Riely, Rina Hui, David P. Carbone et al. · Journal of Thoracic Oncology · 2018 · 23 citations

Tki-resistant/egfr-mutated Advanced Nsclc, Medicine, Immunology +8

Preparation and Characterization of Colon-Specific Microspheres of Diclofenac for Colorectal Cancer

T. Dang, Yuping Cui, Ying Chen et al. · Tropical Journal of Pharmaceutical Research · 2015 · 17 citations · Full text

Ethyl Cellulose, Biomedical Engineering, Oncology +16

1313P Phase III LEAP-006 safety run-in (Part 1): 1L pembrolizumab (Pembro) + chemotherapy (Chemo) with lenvatinib (Len) for metastatic NSCLC

Makoto Nishio, Nir Peled, Alona Zer et al. · Annals of Oncology · 2020 · 14 citations · Full text

Part 1, Oncology, Pharmacology +6

Effects of chronic dietary aluminum on local cerebral glucose utilization in rats

Martin Clauberg, Carolyn B. Smith, T. Dang et al. · Neurobiology of Aging · 1994 · 11 citations

Nutrition, Chronic Dietary Aluminum, Physiology +6